Nuclear receptors in cell life and death
暂无分享,去创建一个
[1] P. Herrlich,et al. Transcriptional cross-talk, the second mode of steroid hormone receptor action , 1998, Journal of Molecular Medicine.
[2] K. Korach. Insights from the study of animals lacking functional estrogen receptor. , 1994, Science.
[3] C. Fabian. Breast cancer chemoprevention: beyond tamoxifen , 2001, Breast Cancer Research.
[4] J. Dussault,et al. Thyroid hormones and brain development. , 1987, Annual review of physiology.
[5] J. Gustafsson,et al. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. , 2001, Cancer research.
[6] D. Bernhard,et al. Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid‐induced apoptosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] P. Goss,et al. Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.
[8] L. Altucci,et al. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. , 2001, Molecular endocrinology.
[9] P. Fenaux,et al. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. , 2001, Seminars in hematology.
[10] K. Korach,et al. Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.
[11] H. Gronemeyer,et al. Therapeutic potential of selective modulators of nuclear receptor action. , 1998, Current opinion in chemical biology.
[12] E. Thompson,et al. Mechanisms of T-cell Apoptosis Induced by Glucocorticoids , 1999, Trends in Endocrinology & Metabolism.
[13] P. Chambon. A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] Elizabeth Gould,et al. Stress and hippocampal neurogenesis , 1999, Biological Psychiatry.
[15] T. McDonnell,et al. Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. , 2000, Endocrinology.
[16] John Calvin Reed,et al. Apoptosis in Xenopus tadpole tail muscles involves Bax‐dependent pathways , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] M. Sporn,et al. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. , 1999, Journal of the National Cancer Institute.
[18] L. Andersson,et al. A role for estrogen receptor β in the regulation of growth of the ventral prostate , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] R. Weinberg,et al. AIB1 enhances estrogen-dependent induction of cyclin D1 expression. , 2001, Cancer research.
[20] J. Isaacs,et al. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer , 1996, The Prostate.
[21] P. Chambon,et al. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. , 1999, Developmental biology.
[22] J. Bernal. Thyroid hormones and brain development. , 1995, Vitamins and hormones.
[23] A. Robles,et al. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[24] Y. Geng,et al. Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.
[25] M. Merino,et al. Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] R. Buckle,et al. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. , 1998, Genes & development.
[27] L. Altucci,et al. 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.
[28] A. Suzuki,et al. Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. , 1996, Oncogene.
[29] S. Cowley,et al. Estrogen Receptors α and β Form Heterodimers on DNA* , 1997, The Journal of Biological Chemistry.
[30] H. Gronemeyer,et al. Transcription factors 3: nuclear receptors. , 1995, Protein profile.
[31] Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. , 2001, Molecular endocrinology.
[32] M. Tsai,et al. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. , 1997, Cancer research.
[33] A. Iavarone,et al. Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. , 1999, Blood.
[34] J. Gustafsson,et al. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. , 1997, Molecular endocrinology.
[35] S. Lippman,et al. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. , 1999, Cancer research.
[36] G. Buchanan,et al. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[37] U. Veronesi,et al. Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide. , 1995, Annals of the New York Academy of Sciences.
[38] P. Hershberger,et al. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. , 1999, Cancer research.
[39] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[40] C. Powers,et al. Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.
[41] R A Irvine,et al. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. , 2000, Cancer research.
[42] L. Gerschenson,et al. Hormonal regulation of cell death in rabbit uterine epithelium. , 1987, The American journal of pathology.
[43] R. Bernards,et al. CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.
[44] P. Chambon,et al. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development , 1999, Nature Genetics.
[45] B. McEwen,et al. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus , 1997, Journal of Chemical Neuroanatomy.
[46] S. Pilkis,et al. Rat liver 6‐phosphofructo 2‐kinase/ fructose 2,6‐bisphosphatase: A review of relationships between the two activities of the enzyme , 1984, Journal of cellular biochemistry.
[47] S. Tabibzadeh. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. , 1996, Molecular human reproduction.
[48] J. Mester,et al. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Graham,et al. Physiological action of progesterone in target tissues. , 1997, Endocrine reviews.
[50] S. Elledge,et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.
[51] J. Gustafsson,et al. Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[52] E. Perez,et al. Breast cancer prevention trials , 2000, Current oncology reports.
[53] R. Sutherland,et al. Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins , 1998, Molecular and Cellular Biology.
[54] A. Iavarone,et al. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. , 1996, The Journal of biological chemistry.
[55] Emma Lees,et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.
[56] G. Shyamala,et al. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. , 1994, Endocrinology.
[57] 橋本 貢士. An unliganded thyroid hormone receptor causes severe neurological dysfunction , 2002 .
[58] J. Welsh. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[59] M. Jäättelä,et al. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. , 1999, Cancer research.
[60] C. Carlberg,et al. Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analogues , 1998, Cell Death and Differentiation.
[61] G. Bubley,et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.
[62] L J Peters,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.
[63] S. Haslam,et al. Role of epidermal growth factor in the acquisition of ovarian steroid hormone responsiveness in the normal mouse mammary gland , 1998, Journal of cellular physiology.
[64] R. Sutherland,et al. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. , 1997, Molecular endocrinology.
[65] L. Altucci,et al. RAR‐independent RXR signaling induces t(15;17) leukemia cell maturation , 1999, The EMBO journal.
[66] K. Kaestner,et al. DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.
[67] W. Liu,et al. Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. , 1999, Cancer research.
[68] L. Salamonsen. Current Concepts of the Mechanisms of Menstruation: A Normal Process of Tissue Destruction , 1998, Trends in Endocrinology & Metabolism.
[69] C. Haslett,et al. Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. , 1999, Trends in pharmacological sciences.
[70] A. Lupulescu. Estrogen use and cancer incidence: a review. , 1995, Cancer investigation.
[71] T. Bäckström,et al. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. , 1999, The Journal of clinical endocrinology and metabolism.
[72] M. Beato,et al. Progestins Prevent Apoptosis in a Rat Endometrial Cell Line and Increase the Ratio of bcl-X L tobcl-X S * , 1997, The Journal of Biological Chemistry.
[73] J. Gustafsson,et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] K. Korach,et al. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[75] J. Welsh,et al. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. , 1998, Endocrinology.
[76] R. Gallagher,et al. The molecular biology of acute promyelocytic leukemia. , 1999, Cancer treatment and research.
[77] Philippe Kastner,et al. Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life? , 1995, Cell.
[78] S. Minucci,et al. Retinoid receptors in health and disease: co-regulators and the chromatin connection. , 1999, Seminars in cell & developmental biology.
[79] Betty H. Johnson,et al. Glucocorticoids, oxysterols, and cAMP with glucocorticoids each cause apoptosis of CEM cells and suppress c-myc , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[80] K. Korach,et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[81] P. Fenaux,et al. Differentiation therapy for acute promyelocytic leukemia. , 1997, The New England journal of medicine.
[82] O. Jänne,et al. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. , 2001, Molecular endocrinology.
[83] G. Stamp,et al. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.
[84] S. J. Higgins,et al. The endocrinology and developmental biology of the prostate. , 1987, Endocrine reviews.
[85] C. Paraskeva,et al. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. , 2000, Cancer research.
[86] K. Burnstein,et al. Antiproliferative Effect of 1α,25-Dihydroxyvitamin D3 in Human Prostate Cancer Cell Line LNCaP Involves Reduction of Cyclin-Dependent Kinase 2 Activity and Persistent G1 Accumulation. , 1998, Endocrinology.
[87] M. Sporn,et al. Role of retinoids in differentiation and carcinogenesis. , 1983, Cancer research.
[88] K. Miyazono,et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.
[89] W. Hong,et al. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. , 2000, Cancer research.
[90] L. Wakefield,et al. Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system , 2000, Breast Cancer Research.
[91] M. J. van de Vijver,et al. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast , 1999, The Journal of pathology.
[92] J. Swinnen,et al. E2F activity is biphasically regulated by androgens in LNCaP cells. , 2001, Biochemical and biophysical research communications.
[93] B. O’Malley,et al. Reproductive phenotypes of the progesterone receptor null mutant mouse , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[94] P. Chambon,et al. RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation. , 1995, The EMBO journal.
[95] L. Altucci,et al. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL , 2001, Nature Medicine.
[96] John Calvin Reed,et al. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. , 1997, The Journal of clinical endocrinology and metabolism.
[97] Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus. , 1997, Endocrinology.
[98] F. Tronche,et al. New insights into glucocorticoid and mineralocorticoid signaling: lessons from gene targeting. , 2000, Advances in pharmacology.
[99] R. Bouillon,et al. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. , 2000, Cancer research.
[100] R. Lotan,et al. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells , 2000, Oncogene.
[101] A. Bilancio,et al. Steroid‐induced androgen receptor–oestradiol receptor β–Src complex triggers prostate cancer cell proliferation , 2000, The EMBO journal.
[102] J. Ashwell,et al. Glucocorticoids in T cell development and function*. , 2000, Annual review of immunology.
[103] W. Hong,et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.
[104] L. Freedman,et al. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. , 1996, Genes & development.
[105] M. Merino,et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.
[106] J. Eisman,et al. Cross-talk between 1,25-Dihydroxyvitamin D3 and Transforming Growth Factor-β Signaling Requires Binding of VDR and Smad3 Proteins to Their Cognate DNA Recognition Elements* , 2001, The Journal of Biological Chemistry.
[107] M. Sporn. New Agents for Chemoprevention of Prostate Cancer , 1999, European Urology.
[108] R. Lotan,et al. Inhibition of tumor cell growth by retinoids. , 1990, Methods in enzymology.
[109] H. Adami,et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study , 1999, The Lancet.
[110] M. Sherman. Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach , 2000, Modern Pathology.
[111] T. Mcguire,et al. Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. , 2001, The Journal of biological chemistry.